Development of a scalable single process for producing SARS-CoV-2 RBD monomer and dimer vaccine antigens. 2023

Tammy Boggiano-Ayo, and Julio Palacios-Oliva, and Sumlai Lozada-Chang, and Ernesto Relova-Hernandez, and Jose Gomez-Perez, and Gonzalo Oliva, and Lourdes Hernandez, and Alexi Bueno-Soler, and Daidee Montes de Oca, and Osvaldo Mora, and Roberto Machado-Santisteban, and Dayana Perez-Martinez, and Beatriz Perez-Masson, and Yanelys Cabrera Infante, and Lisandra Calzadilla-Rosado, and Yaima Ramirez, and Judey Aymed-Garcia, and Ingrid Ruiz-Ramirez, and Yamile Romero, and Tania Gomez, and Luis A Espinosa, and Luis Javier Gonzalez, and Annia Cabrales, and Osmany Guirola, and Kathya Rashida de la Luz, and Franciscary Pi-Estopiñan, and Belinda Sanchez-Ramirez, and Dagmar Garcia-Rivera, and Yuri Valdes-Balbin, and Gertrudis Rojas, and Kalet Leon-Monzon, and Eduardo Ojito-Magaz, and Eugenio Hardy
Process Development Direction, Center of Molecular Immunology, Havana, Cuba.

We have developed a single process for producing two key COVID-19 vaccine antigens: SARS-CoV-2 receptor binding domain (RBD) monomer and dimer. These antigens are featured in various COVID-19 vaccine formats, including SOBERANA 01 and the licensed SOBERANA 02, and SOBERANA Plus. Our approach involves expressing RBD (319-541)-His6 in Chinese hamster ovary (CHO)-K1 cells, generating and characterizing oligoclones, and selecting the best RBD-producing clones. Critical parameters such as copper supplementation in the culture medium and cell viability influenced the yield of RBD dimer. The purification of RBD involved standard immobilized metal ion affinity chromatography (IMAC), ion exchange chromatography, and size exclusion chromatography. Our findings suggest that copper can improve IMAC performance. Efficient RBD production was achieved using small-scale bioreactor cell culture (2 L). The two RBD forms - monomeric and dimeric RBD - were also produced on a large scale (500 L). This study represents the first large-scale application of perfusion culture for the production of RBD antigens. We conducted a thorough analysis of the purified RBD antigens, which encompassed primary structure, protein integrity, N-glycosylation, size, purity, secondary and tertiary structures, isoform composition, hydrophobicity, and long-term stability. Additionally, we investigated RBD-ACE2 interactions, in vitro ACE2 recognition of RBD, and the immunogenicity of RBD antigens in mice. We have determined that both the monomeric and dimeric RBD antigens possess the necessary quality attributes for vaccine production. By enabling the customizable production of both RBD forms, this unified manufacturing process provides the required flexibility to adapt rapidly to the ever-changing demands of emerging SARS-CoV-2 variants and different COVID-19 vaccine platforms.

UI MeSH Term Description Entries

Related Publications

Tammy Boggiano-Ayo, and Julio Palacios-Oliva, and Sumlai Lozada-Chang, and Ernesto Relova-Hernandez, and Jose Gomez-Perez, and Gonzalo Oliva, and Lourdes Hernandez, and Alexi Bueno-Soler, and Daidee Montes de Oca, and Osvaldo Mora, and Roberto Machado-Santisteban, and Dayana Perez-Martinez, and Beatriz Perez-Masson, and Yanelys Cabrera Infante, and Lisandra Calzadilla-Rosado, and Yaima Ramirez, and Judey Aymed-Garcia, and Ingrid Ruiz-Ramirez, and Yamile Romero, and Tania Gomez, and Luis A Espinosa, and Luis Javier Gonzalez, and Annia Cabrales, and Osmany Guirola, and Kathya Rashida de la Luz, and Franciscary Pi-Estopiñan, and Belinda Sanchez-Ramirez, and Dagmar Garcia-Rivera, and Yuri Valdes-Balbin, and Gertrudis Rojas, and Kalet Leon-Monzon, and Eduardo Ojito-Magaz, and Eugenio Hardy
September 2021, Viruses,
Tammy Boggiano-Ayo, and Julio Palacios-Oliva, and Sumlai Lozada-Chang, and Ernesto Relova-Hernandez, and Jose Gomez-Perez, and Gonzalo Oliva, and Lourdes Hernandez, and Alexi Bueno-Soler, and Daidee Montes de Oca, and Osvaldo Mora, and Roberto Machado-Santisteban, and Dayana Perez-Martinez, and Beatriz Perez-Masson, and Yanelys Cabrera Infante, and Lisandra Calzadilla-Rosado, and Yaima Ramirez, and Judey Aymed-Garcia, and Ingrid Ruiz-Ramirez, and Yamile Romero, and Tania Gomez, and Luis A Espinosa, and Luis Javier Gonzalez, and Annia Cabrales, and Osmany Guirola, and Kathya Rashida de la Luz, and Franciscary Pi-Estopiñan, and Belinda Sanchez-Ramirez, and Dagmar Garcia-Rivera, and Yuri Valdes-Balbin, and Gertrudis Rojas, and Kalet Leon-Monzon, and Eduardo Ojito-Magaz, and Eugenio Hardy
June 2023, Process biochemistry (Barking, London, England),
Tammy Boggiano-Ayo, and Julio Palacios-Oliva, and Sumlai Lozada-Chang, and Ernesto Relova-Hernandez, and Jose Gomez-Perez, and Gonzalo Oliva, and Lourdes Hernandez, and Alexi Bueno-Soler, and Daidee Montes de Oca, and Osvaldo Mora, and Roberto Machado-Santisteban, and Dayana Perez-Martinez, and Beatriz Perez-Masson, and Yanelys Cabrera Infante, and Lisandra Calzadilla-Rosado, and Yaima Ramirez, and Judey Aymed-Garcia, and Ingrid Ruiz-Ramirez, and Yamile Romero, and Tania Gomez, and Luis A Espinosa, and Luis Javier Gonzalez, and Annia Cabrales, and Osmany Guirola, and Kathya Rashida de la Luz, and Franciscary Pi-Estopiñan, and Belinda Sanchez-Ramirez, and Dagmar Garcia-Rivera, and Yuri Valdes-Balbin, and Gertrudis Rojas, and Kalet Leon-Monzon, and Eduardo Ojito-Magaz, and Eugenio Hardy
September 2021, Cell research,
Tammy Boggiano-Ayo, and Julio Palacios-Oliva, and Sumlai Lozada-Chang, and Ernesto Relova-Hernandez, and Jose Gomez-Perez, and Gonzalo Oliva, and Lourdes Hernandez, and Alexi Bueno-Soler, and Daidee Montes de Oca, and Osvaldo Mora, and Roberto Machado-Santisteban, and Dayana Perez-Martinez, and Beatriz Perez-Masson, and Yanelys Cabrera Infante, and Lisandra Calzadilla-Rosado, and Yaima Ramirez, and Judey Aymed-Garcia, and Ingrid Ruiz-Ramirez, and Yamile Romero, and Tania Gomez, and Luis A Espinosa, and Luis Javier Gonzalez, and Annia Cabrales, and Osmany Guirola, and Kathya Rashida de la Luz, and Franciscary Pi-Estopiñan, and Belinda Sanchez-Ramirez, and Dagmar Garcia-Rivera, and Yuri Valdes-Balbin, and Gertrudis Rojas, and Kalet Leon-Monzon, and Eduardo Ojito-Magaz, and Eugenio Hardy
October 2022, Vaccines,
Tammy Boggiano-Ayo, and Julio Palacios-Oliva, and Sumlai Lozada-Chang, and Ernesto Relova-Hernandez, and Jose Gomez-Perez, and Gonzalo Oliva, and Lourdes Hernandez, and Alexi Bueno-Soler, and Daidee Montes de Oca, and Osvaldo Mora, and Roberto Machado-Santisteban, and Dayana Perez-Martinez, and Beatriz Perez-Masson, and Yanelys Cabrera Infante, and Lisandra Calzadilla-Rosado, and Yaima Ramirez, and Judey Aymed-Garcia, and Ingrid Ruiz-Ramirez, and Yamile Romero, and Tania Gomez, and Luis A Espinosa, and Luis Javier Gonzalez, and Annia Cabrales, and Osmany Guirola, and Kathya Rashida de la Luz, and Franciscary Pi-Estopiñan, and Belinda Sanchez-Ramirez, and Dagmar Garcia-Rivera, and Yuri Valdes-Balbin, and Gertrudis Rojas, and Kalet Leon-Monzon, and Eduardo Ojito-Magaz, and Eugenio Hardy
December 2022, International journal of biological macromolecules,
Tammy Boggiano-Ayo, and Julio Palacios-Oliva, and Sumlai Lozada-Chang, and Ernesto Relova-Hernandez, and Jose Gomez-Perez, and Gonzalo Oliva, and Lourdes Hernandez, and Alexi Bueno-Soler, and Daidee Montes de Oca, and Osvaldo Mora, and Roberto Machado-Santisteban, and Dayana Perez-Martinez, and Beatriz Perez-Masson, and Yanelys Cabrera Infante, and Lisandra Calzadilla-Rosado, and Yaima Ramirez, and Judey Aymed-Garcia, and Ingrid Ruiz-Ramirez, and Yamile Romero, and Tania Gomez, and Luis A Espinosa, and Luis Javier Gonzalez, and Annia Cabrales, and Osmany Guirola, and Kathya Rashida de la Luz, and Franciscary Pi-Estopiñan, and Belinda Sanchez-Ramirez, and Dagmar Garcia-Rivera, and Yuri Valdes-Balbin, and Gertrudis Rojas, and Kalet Leon-Monzon, and Eduardo Ojito-Magaz, and Eugenio Hardy
July 2022, Annals of clinical and laboratory science,
Tammy Boggiano-Ayo, and Julio Palacios-Oliva, and Sumlai Lozada-Chang, and Ernesto Relova-Hernandez, and Jose Gomez-Perez, and Gonzalo Oliva, and Lourdes Hernandez, and Alexi Bueno-Soler, and Daidee Montes de Oca, and Osvaldo Mora, and Roberto Machado-Santisteban, and Dayana Perez-Martinez, and Beatriz Perez-Masson, and Yanelys Cabrera Infante, and Lisandra Calzadilla-Rosado, and Yaima Ramirez, and Judey Aymed-Garcia, and Ingrid Ruiz-Ramirez, and Yamile Romero, and Tania Gomez, and Luis A Espinosa, and Luis Javier Gonzalez, and Annia Cabrales, and Osmany Guirola, and Kathya Rashida de la Luz, and Franciscary Pi-Estopiñan, and Belinda Sanchez-Ramirez, and Dagmar Garcia-Rivera, and Yuri Valdes-Balbin, and Gertrudis Rojas, and Kalet Leon-Monzon, and Eduardo Ojito-Magaz, and Eugenio Hardy
November 2021, Cell research,
Tammy Boggiano-Ayo, and Julio Palacios-Oliva, and Sumlai Lozada-Chang, and Ernesto Relova-Hernandez, and Jose Gomez-Perez, and Gonzalo Oliva, and Lourdes Hernandez, and Alexi Bueno-Soler, and Daidee Montes de Oca, and Osvaldo Mora, and Roberto Machado-Santisteban, and Dayana Perez-Martinez, and Beatriz Perez-Masson, and Yanelys Cabrera Infante, and Lisandra Calzadilla-Rosado, and Yaima Ramirez, and Judey Aymed-Garcia, and Ingrid Ruiz-Ramirez, and Yamile Romero, and Tania Gomez, and Luis A Espinosa, and Luis Javier Gonzalez, and Annia Cabrales, and Osmany Guirola, and Kathya Rashida de la Luz, and Franciscary Pi-Estopiñan, and Belinda Sanchez-Ramirez, and Dagmar Garcia-Rivera, and Yuri Valdes-Balbin, and Gertrudis Rojas, and Kalet Leon-Monzon, and Eduardo Ojito-Magaz, and Eugenio Hardy
May 2022, Pharmaceutics,
Tammy Boggiano-Ayo, and Julio Palacios-Oliva, and Sumlai Lozada-Chang, and Ernesto Relova-Hernandez, and Jose Gomez-Perez, and Gonzalo Oliva, and Lourdes Hernandez, and Alexi Bueno-Soler, and Daidee Montes de Oca, and Osvaldo Mora, and Roberto Machado-Santisteban, and Dayana Perez-Martinez, and Beatriz Perez-Masson, and Yanelys Cabrera Infante, and Lisandra Calzadilla-Rosado, and Yaima Ramirez, and Judey Aymed-Garcia, and Ingrid Ruiz-Ramirez, and Yamile Romero, and Tania Gomez, and Luis A Espinosa, and Luis Javier Gonzalez, and Annia Cabrales, and Osmany Guirola, and Kathya Rashida de la Luz, and Franciscary Pi-Estopiñan, and Belinda Sanchez-Ramirez, and Dagmar Garcia-Rivera, and Yuri Valdes-Balbin, and Gertrudis Rojas, and Kalet Leon-Monzon, and Eduardo Ojito-Magaz, and Eugenio Hardy
March 2023, Biotechnology reports (Amsterdam, Netherlands),
Tammy Boggiano-Ayo, and Julio Palacios-Oliva, and Sumlai Lozada-Chang, and Ernesto Relova-Hernandez, and Jose Gomez-Perez, and Gonzalo Oliva, and Lourdes Hernandez, and Alexi Bueno-Soler, and Daidee Montes de Oca, and Osvaldo Mora, and Roberto Machado-Santisteban, and Dayana Perez-Martinez, and Beatriz Perez-Masson, and Yanelys Cabrera Infante, and Lisandra Calzadilla-Rosado, and Yaima Ramirez, and Judey Aymed-Garcia, and Ingrid Ruiz-Ramirez, and Yamile Romero, and Tania Gomez, and Luis A Espinosa, and Luis Javier Gonzalez, and Annia Cabrales, and Osmany Guirola, and Kathya Rashida de la Luz, and Franciscary Pi-Estopiñan, and Belinda Sanchez-Ramirez, and Dagmar Garcia-Rivera, and Yuri Valdes-Balbin, and Gertrudis Rojas, and Kalet Leon-Monzon, and Eduardo Ojito-Magaz, and Eugenio Hardy
January 2023, Frontiers in immunology,
Copied contents to your clipboard!